Research Article

Development of Immunocapture-LC/MS Assay for Simultaneous ADA Isotyping and Semiquantitation

Table 3

LC/MS peak area ratio responses and calculated ADA isotope/subclass levels in PEA positive human plasma with drug as ADA capture reagent (numbers in bold italic are above respective cut-points).

Lot #IgG1IgG1 conc. (µg/mL)IgG2IgG3IG4IgEIgMIgA1 + IgA2

10.08740.00330.04760.00960.04990.0441
20.08380.04520.07620.00700.04210.0422
30.42000.6600.00610.02630.00880.01110.0847
40.19700.00470.00200.01130.00680.0497
50.02390.00440.01190.00200.00070.0480
60.08270.01410.02050.01920.00540.03160.0771
70.01880.00410.01270.0239
80.01500.01090.03150.00170.01190.00270.0712
90.07880.00090.00090.01500.00990.0727
100.06410.00760.01920.01550.03140.0424
110.43300.6800.00410.03030.00310.10100.0652

Cut point (95%)0.05070.02240.04160.02650.01830.08540.0160

—: below the limit of quantitation for IgG1 concentration or no peak was detected for other isotypes/subclasses.